Hannah Archibald, MD
Volunteer Clinical Instructor
Medicine
School of Medicine

Publications (5)

Top publication keywords:
Myeloid Cell Leukemia Sequence 1 ProteinMolecular Targeted TherapyBcl-2-Like Protein 11Gene Expression Regulation, NeoplasticDrug Resistance, NeoplasmLung NeoplasmsMitogen-Activated Protein Kinase KinasesCarcinoma, Non-Small-Cell LungEpithelial-Mesenchymal TransitionProtein Kinase InhibitorsProto-Oncogene Proteins p21(ras)Cytidine DeaminaseQuinazolinesTeaching RoundsErbB Receptors

• Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
  Nature 2023 Isozaki H, Sakhtemani R, Abbasi A, Nikpour N, Stanzione M, Oh S, Langenbucher A, Monroe S, Su W, Cabanos HF, Siddiqui FM, Phan N, Jalili P, Timonina D, Bilton S, Gomez-Caraballo M, Archibald HL, …
• NET Rounding: a novel approach to efficient and effective rounds for the modern clinical learning environment.
  BMC medical education 2022 Chan SJ, Archibald HL, Conner SM
• Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer.
  Cancer discovery 2018 Nangia V, Siddiqui FM, Caenepeel S, Timonina D, Bilton SJ, Phan N, Gomez-Caraballo M, Archibald HL, Li C, Fraser C, Rigas D, Vajda K, Ferris LA, Lanuti M, Wright CD, Raskin KA, Cahill DP, Shin JH, …
• Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Song KA, Niederst MJ, Lochmann TL, Hata AN, Kitai H, Ham J, Floros KV, Hicks MA, Hu H, Mulvey HE, Drier Y, Heisey DAR, Hughes MT, Patel NU, Lockerman EL, Garcia A, Gillepsie S, Archibald HL, Gomez-…
• Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.
  Nature medicine 2016 Hata AN, Niederst MJ, Archibald HL, Gomez-Caraballo M, Siddiqui FM, Mulvey HE, Maruvka YE, Ji F, Bhang HE, Krishnamurthy Radhakrishna V, Siravegna G, Hu H, Raoof S, Lockerman E, Kalsy A, Lee D, …